Dexcom is facing scrutiny and class-action lawsuits over alleged safety and accuracy issues with its G7 monitor.

The market awaits DexCom's announcement, with hopes high for news of surpassing estimates and providing upbeat guidance for the next quarter. It's important for new investors to u ...

Spending more time in glucose range could help reduce adverse pregnancy outcomes, but available closed-loop insulin delivery systems are not customized to pregnancy-specific needs. In a randomized ...

Tandem Diabetes Care (Nasdaq:TNDM) today announced the rollout of its latest automated insulin delivery system integration.

IQ+, our most advanced algorithm ever, together with the benefits of Abbott's latest CGM sensor on our tested and trusted ...

Dexcom faces new FDA reports linking its G7 glucose monitor to patient deaths as lawsuits and regulatory scrutiny intensify.

What Happened? Shares of diabetes technology company Tandem Diabetes Care (NASDAQ:TNDM) jumped 1.6% in the afternoon session ...

ViCentra announced today that it appointed former Dexcom and Medtronic Diabetes leaders to new executive roles.

Image from Modular Medical on LinkedIn]Modular Medical (Nasdaq:MODD) announced that it continues to progress toward CE mark ...